X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4) 4
rheumatology (4) 4
female (3) 3
index medicus (3) 3
middle aged (3) 3
scleroderma, systemic - drug therapy (3) 3
systemic sclerosis (3) 3
treatment outcome (3) 3
adult (2) 2
aged (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
clinical trials (2) 2
double-blind method (2) 2
health risk assessment (2) 2
injections, subcutaneous (2) 2
interleukin-6 (2) 2
lung diseases (2) 2
male (2) 2
musculoskeletal diseases (2) 2
patients (2) 2
placebo (2) 2
predictive value of tests (2) 2
safety (2) 2
scleroderma (2) 2
scleroderma, systemic - complications (2) 2
severity of illness index (2) 2
skin (2) 2
skin and connective tissue diseases (2) 2
studies (2) 2
survival (2) 2
time factors (2) 2
1506 (1) 1
2311 (1) 1
abridged index medicus (1) 1
acute kidney injury - diagnosis (1) 1
acute kidney injury - drug therapy (1) 1
acute kidney injury - etiology (1) 1
acute kidney injury - physiopathology (1) 1
adults (1) 1
analysis (1) 1
anemia, hemolytic - diagnosis (1) 1
anemia, hemolytic - etiology (1) 1
angiotensin ii type 1 receptor blockers - therapeutic use (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
antibodies (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antihypertensive agents - therapeutic use (1) 1
antirheumatic agents - administration & dosage (1) 1
antirheumatic agents - adverse effects (1) 1
arthritis (1) 1
association (1) 1
autoimmune diseases (1) 1
biomarkers (1) 1
biomarkers - metabolism (1) 1
calcinosis - diagnostic imaging (1) 1
canada (1) 1
captopril - therapeutic use (1) 1
clinical and epidemiological research (1) 1
clinical trial, phase ii (1) 1
clinical-trial (1) 1
cohort (1) 1
complications (1) 1
connective-tissue disease (1) 1
cost-benefit analysis (1) 1
cutis (1) 1
cytokines (1) 1
delayed diagnosis (1) 1
diffuse scleroderma (1) 1
disease (1) 1
dmards (1) 1
dmards, interleukin-6, scleroderma, systemic sclerosis (1) 1
double-blind (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
effectiveness (1) 1
europe (1) 1
expression (1) 1
failure (1) 1
feasibility studies (1) 1
fibroblasts (1) 1
hand - diagnostic imaging (1) 1
hypertension, malignant - diagnosis (1) 1
hypertension, malignant - drug therapy (1) 1
hypertension, malignant - etiology (1) 1
hypertension, malignant - physiopathology (1) 1
interleukin (1) 1
interleukin 6 (1) 1
interleukin-6 - physiology (1) 1
interleukins (1) 1
internal medicine (1) 1
interstitial lung-disease (1) 1
involvement (1) 1
itching (1) 1
journal article (1) 1
least squares (1) 1
literature review (1) 1
long-term outcomes (1) 1
lung-disease (1) 1
lysophosphatidic acid (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 06/2016, Volume 387, Issue 10038, pp. 2630 - 2640
Summary Background Systemic sclerosis is a rare disabling autoimmune disease with few treatment options. The efficacy and safety of tocilizumab, an interleukin... 
Internal Medicine | Medicine(all) | Multicenter Study | Clinical Trial, Phase II | Randomized Controlled Trial | Research Support, Non-U.S. Gov't | Journal Article | INTERSTITIAL LUNG-DISEASE | MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PLACEBO | LYSOPHOSPHATIDIC ACID | DIFFUSE SCLERODERMA | SKIN FIBROSIS | INTERLEUKIN-6 | EXPRESSION | SSC SKIN | Biomarkers - metabolism | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Europe | Humans | Middle Aged | Scleroderma, Systemic - metabolism | Male | Treatment Outcome | United Kingdom | Canada | Vital Capacity | Antibodies, Monoclonal, Humanized - administration & dosage | Injections, Subcutaneous | Scleroderma, Systemic - complications | Interleukin-6 - physiology | Adult | Female | Aged | Scleroderma, Systemic - drug therapy | Medical colleges | Adults | Systemic scleroderma | Interleukins | Scleroderma (Disease) | Analysis | Tissue | Cytokines | Ulcers | Biomarkers | Fibroblasts | Clinical trials | Patient safety | Skin diseases | Skin | Health risk assessment | Scleroderma | Drug therapy | Pathogenesis | Interleukin | Medical services | Itching | Interleukin 6 | Cost-benefit analysis | Safety | Thickening | Effectiveness | Mortality | Lung diseases | Medical treatment | Rheumatology | Patients | Studies | Systemic sclerosis | Least squares | Autoimmune diseases
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2018, Volume 77, Issue 2, pp. 212 - 220
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 2015, Volume 33, Issue 4, pp. S171 - S174
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.